Union 2023 Conference
Paediatric TB: An Overview (India)
TB OPD at Sassoon hospital
Vidya Mave and Aarti Kinikar with text: At this time, it is up to researchers to identify the best combinations of these new drugs that are highly efficacious, the least toxic, and can be easily implemented in programmatic settings.
Mitr Clinic team
1
2
3
4
5
November 9, 2023

CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!

June 26, 2023

Video: Shedding Light on Pediatric TB in India

June 26, 2023

Last year, based on SHINE research, the WHO strongly recommended shortening the TB treatment duration in non-severe paediatric TB cases from six-four months.

June 13, 2023

Recent studies have found that the length of time tuberculosis patients need to stay on their regimen can be reduced from six to four months.

June 8, 2023

On Wednesday, June 7th, CIDI celebrated Pride Month at the event "Pride & Beyond: Addressing Health Equity for LGBTQIA+ People in India."

DEVELOPMENTS NEWS ENGAGE
Amita Gupta, MD, MHS

Deferral of maternal isoniazid preventive therapy to early postpartum had no effect on infant tuberculosis acquisition in our trial population, regardless of the diagnostic test used.

Dr. Vidya Mave and colleagues concluded considerable intrahost mycobacterium tuberculosis mutation rates were present at recurrence among patients with diabetes mellitus. 

Akshay Gupte

Dr. Akshay Gupte and team found females were 7 times more likely to have restrictive spirometry pattern and 22 times more likely to have preserved ratio impaired spirometry, compared with men.

CIDI team at a table

Check out the photo gallery from CIDI at the 2023 Union Conference on Lung Health.

Union 2023 Conference

CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!

Counsellors visit patients ' homes

A novel trial is underway in Pune to provide evidence on how best to find people with recurrent Tuberculosis (TB), so that they can be quickly linked to care.

A sexual health manager at Safe Zindagi explains the HIV self-testing process to a client. (Photograph courtesy Safe Zindagi)

Safe Zindagi, an online portal funded by USAID and PEPFAR, provides HIV care and services to hard-to-reach populations in India.

USAID-supported Adolescent-Friendly Health Centers create a supportive youth-led community that can help HIV positive children navigate challenges. (Photograph courtesy ACCELERATE)

USAID, with support of PEPFAR, set up Adolescent-Friendly Health Centers through its flagship program, ACCELERATE, led by Johns Hopkins University School of Medicine, to support 10-17-year-old HIV positive adolescents with comprehensive health care and services.

Woman showing a diagram to a patient

Interim results are “promising” and show that a short treatment regimen called “3HP” could pave the way in preventing TB.